Research & Development
A deeply integrated, multi-disciplinary R&D approach that generates defensible IP and high-margin clinical ingredients.
Six Disciplines. One System.
Our deeply integrated R&D approach, spanning precision agronomy, bioactive pathway optimisation, and digital process control, systematically generates novel methodologies and proprietary innovations. This robust, multi-disciplinary intellectual property is highly defensible, establishing significant barriers to entry for competitors.
Precision Agronomy
Controlled light spectra, VPD, CO₂ and nutrient delivery tuned per crop and per bioactive target. Trials run in partnership with Stirling Plant Sciences.
Bioactive Pathway Optimisation
Stress-elicitation, photoperiod manipulation and fertigation adjustment to push glucosinolates, polyphenols, nitrates and other markers 3–8× above field-grown levels.
Analytical Chemistry
HPLC, mass-spectrometry and ATP-swab validation at each harvest batch, creating a closed-loop feedback system that targets specific bioactive concentration bands.
Digital Process Control
Digital-twin crop modelling with Stirling Engineering translates validated 'recipes' into predictive control algorithms that reduce energy-per-kg and improve consistency.
Renewable Energy CEA
BioLabs™ microgrid integration cuts operating costs and supports Net Zero objectives. BioCubes are engineered for low-CAPEX, off-grid-ready deployment.
Clinical Dietetics
Nutrient profiles are mapped with clinical dietetics oversight, ensuring bioactive frameworks meet medical-grade application standards for GLP-1, sports and pharmaceutical supply chains.
The Future: Peptide Research

Manufacturing Peptides & Therapeutic Proteins

Traction to Date
12–24 Month R&D Plan
- IP filings for growing protocols
- First BioCubes manufacture
- Analytical assays with partnered labs
- SEIS/EIS close
- Initial clinical diet mapping complete
- Multi-cube R&D site at NEXUS
- GACP & ISO 22000 certification pathway
- First B2B supply contracts / HMPPS partnership
- White-label sports product launch
- 30–50 BioCubes in operation
- International licensing (UK, EU & Caribbean)
- Strong recurring B2B sales
- Profitability achieved







